Moreover, co-expression studies revealed that SSP1-CD44 axis deregulation identifies the same group of miRNA involved in transforming NSCLC into SCLC mediated by a multidrug-resistant cancer stem cells acquisition, thus modulating the cancer phenotypes transition in acquiring resistance to TKI process (51). This evidence concerns the gene CD44 and non-small cell lung carcinoma.